Brandinium

Trademark search for:

SIMPRE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-12-12 — Application filed
  • 2023-12-15 — Application filed
  • 2023-12-27 — Teas voluntary amendment received
  • 2024-01-26 — Application filed
  • 2024-06-26 — Assigned to lie
  • 2024-06-26 — Preliminary/voluntary amendment - entered
  • 2024-07-11 — Assigned to examiner
  • 2024-07-13 — Final disposition recorded
  • 2024-07-13 — Final disposition recorded
  • 2024-07-13 — Final disposition recorded
  • 2024-07-15 — Approved for pub - principal register
  • 2024-07-31 — Notification of notice of publication e-mailed
  • 2024-08-20 — Published for opposition
  • 2024-08-20 — Official gazette publication confirmation e-mailed
  • 2024-10-15 — Noa e-mailed - sou required from applicant
  • 2025-02-24 — Sou teas extension received
  • 2025-02-24 — Sou extension 1 filed
  • 2025-02-24 — Sou extension 1 granted
  • 2025-02-24 — Notice of approval of extension request e-mailed
  • 2025-06-30 — Teas revoke/app/change addr of atty/dom rep received
  • 2025-06-30 — Attorney/dom.rep.revoked and/or appointed
  • 2025-06-30 — Teas change of domestic representatives address
  • 2025-06-30 — Teas change of correspondence received
  • 2025-06-30 — Teas withdrawal of attorney received-firm retains
  • 2025-11-17 — Application abandoned
  • 2025-11-17 — Application abandoned
  • 2025-11-17 — Final status recorded

Owner Information

Sanofi
Paris FR
Sanofi
Paris FR

Correspondent

Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th FL
New York, NY 10036
United States

Filing Details

Filing Date:
2023-12-12
Status Date:
2025-11-17
Category:
Pharmaceuticals
Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.